Preventing Ocular Surface Disease in Contact-Lens Users

Abstract

Ocular surface disease (OSD) represents a significant complication among contact-lens users, with multifactorial etiology and complex pathophysiology. This review synthesizes current evidence on the epidemiology, mechanisms, risk factors, clinical features, diagnostic criteria, and management strategies, emphasizing prevention in at-risk populations. Recent advances in lens technology, care regimens, and guideline-based recommendations are integrated to provide a comprehensive, clinically relevant resource for healthcare professionals.

Introduction

Contact lenses are widely utilized for vision correction and cosmetic purposes; however, their use is associated with various ocular surface complications, collectively termed ocular surface disease (OSD). This encompasses a spectrum of disorders including contact lens-induced dry eye, meibomian gland dysfunction, and allergic conjunctivitis. The multifaceted interplay between lens materials, hygiene practices, and patient-specific factors necessitates a nuanced understanding for effective prevention and management. Timely recognition and intervention are critical to minimize morbidity and optimize patient outcomes.

Epidemiology / Disease Burden

OSD affects an estimated 30-50% of contact-lens wearers globally, with prevalence varying by population, lens type, and care practices. The widespread use of soft contact lenses, now accounting for over 90% of prescriptions, correlates with increased reports of discomfort and ocular surface changes. The economic and quality-of-life impact is substantial, contributing to contact lens discontinuation in up to 20% of users. Epidemiological studies highlight the burden on healthcare systems, with increased clinic visits, diagnostic interventions, and treatment costs. Notably, the prevalence of OSD is rising in younger demographics, paralleling increased lens use for myopia control and digital lifestyles.

Pathophysiology

The pathogenesis of OSD in contact-lens users is multifactorial, involving mechanical, immunological, and biochemical mechanisms. Contact lenses disrupt the tear film's stability, alter meibomian gland function, and can serve as reservoirs for microbial colonization. Mechanical friction from lens movement induces microtrauma, promoting inflammation and epithelial cell loss. Hypoxia, particularly with low oxygen-permeable lenses, exacerbates epithelial barrier dysfunction and stimulates inflammatory cytokine production. Additionally, preservatives in multipurpose solutions may trigger toxic or allergic responses, contributing to ocular surface inflammation and homeostatic imbalance.

Risk Factors

Intrinsic and extrinsic risk factors modulate susceptibility to OSD. Patient-related factors include age, sex (with increased risk in females), pre-existing dry eye, systemic autoimmune disease, and hormonal influences. Lens-related factors encompass material (hydrogel vs. silicone hydrogel), modality (daily vs. extended wear), and care system (multipurpose solutions vs. hydrogen peroxide-based regimens). Behavioral contributors such as poor hand hygiene, overnight wear, infrequent lens replacement, and exposure to adverse environmental conditions (air conditioning, screen time, low humidity) further increase risk. Recent evidence also implicates digital device use as a modifiable risk factor, given its association with decreased blink rate and incomplete blinking.

Clinical Features

OSD presents with a spectrum of symptoms, including dryness, foreign body sensation, itching, burning, blurred vision, and lens intolerance. Objective signs include conjunctival hyperemia, punctate epithelial erosions, lid margin telangiectasia, and decreased tear break-up time. In severe cases, filamentary keratitis or superior limbic keratoconjunctivitis may develop. Meibomian gland dysfunction is a frequent comorbidity, manifesting as gland dropout, altered expressibility, and frothy tear film. Allergic manifestations, such as giant papillary conjunctivitis, are characterized by papillae on the tarsal conjunctiva and mucous discharge. Early identification of these features is essential to prevent irreversible ocular surface damage.

Diagnosis

The diagnostic approach to OSD in contact-lens users involves a combination of subjective assessment and objective clinical tests. Symptomatology is systematically evaluated using validated questionnaires such as the Ocular Surface Disease Index (OSDI) and Contact Lens Dry Eye Questionnaire (CLDEQ). Slit-lamp biomicroscopy remains the cornerstone for detecting conjunctival and corneal changes, tear film instability, and meibomian gland dysfunction. Ancillary tests include tear break-up time (TBUT), Schirmer test, ocular surface staining (fluorescein, lissamine green), and meibography. Differential diagnosis must exclude infectious keratitis, allergic conjunctivitis unrelated to lens wear, and other causes of ocular surface inflammation.

Treatment & Management

Management strategies emphasize a stepwise, individualized approach. First-line interventions include optimizing lens fit, switching to daily disposable or silicone hydrogel lenses, and improving lens hygiene. Environmental modifications, such as humidifier use and limiting screen time, are recommended. Tear supplementation with preservative-free artificial tears and lipid-based drops can restore tear film stability. Lid hygiene and warm compresses address meibomian gland dysfunction. For refractory cases, anti-inflammatory therapy (topical corticosteroids, cyclosporine, lifitegrast) may be indicated. Discontinuation of lens wear is considered in severe or unresponsive cases. Patient education on proper lens care and adherence to replacement schedules is crucial for long-term disease control.

Recent Advances / Emerging Therapies

Recent innovations in lens materials, including water gradient and surface-modified silicone hydrogels, have demonstrated reduced protein deposition and improved comfort. Novel multipurpose solutions with reduced cytotoxicity are under investigation, aiming to minimize preservative-related toxicity. Antimicrobial coatings and biosensor-integrated lenses offer potential for infection prevention and real-time monitoring of ocular surface health. Clinical trials exploring omega-3 fatty acid supplementation and novel anti-inflammatory agents (e.g., integrin antagonists) are underway. Ongoing research focuses on personalized lens selection based on individual tear film and meibomian gland profiles, heralding a new era of precision contact lens care.

Guideline Recommendations

Consensus guidelines from organizations such as the Tear Film & Ocular Surface Society (TFOS) and American Academy of Ophthalmology advocate for regular screening of contact-lens users for OSD, with emphasis on early symptom recognition and prompt intervention. Recommendations include annual eye examinations, use of daily disposable lenses for at-risk populations, and patient counseling on modifiable risk factors. Clinicians are encouraged to adopt evidence-based protocols for lens care, promote preservative-free lubricants, and integrate meibomian gland assessment into routine practice. Interdisciplinary collaboration with optometrists and primary care providers is advised to ensure comprehensive patient education and follow-up.

Conclusion

Preventing ocular surface disease in contact-lens users requires a multifaceted, evidence-based approach encompassing risk assessment, patient education, optimized lens selection, and early intervention. Advances in lens technology and care regimens, combined with guideline-driven practice, hold promise for reducing disease burden and enhancing patient quality of life. Ongoing research and clinical vigilance are essential to address emerging challenges and optimize preventive strategies in this dynamic field.